Skip to content
value.today

C16 Biosciences, Inc.

Formerly C16, LLC, C16 Biosciences, LLC

Total raised
$29 M
3 rounds on record
Latest round
$5 M
Feb 2023
First round on record
Aug 2018
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of C16 Biosciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2023$5 MNo. 3$2 to $10 million

C16 Biosciences, Inc.: Raise no. 3, Feb 2023

Investors in this round

17 investors had bought by the notice of Mar 22, 2023: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Shara Ticku · Executive Officer, Director, Promoter
  • Harold McNamara · Director
  • Peter Turner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Shara Ticku, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 22, 2023. Read the notice at the SEC.

equitySEC
Feb 2020$20 MNo. 2$10 to $50 million

C16 Biosciences, Inc.: Raise no. 2, Feb 2020

Investors in this round

45 investors had bought by the notice of Mar 11, 2020: 45 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Shara Ticku · Executive Officer, Director, Promoter
  • Harold McNamara · Director, Promoter
  • Peter Turner · Director
  • David Heller · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Shara Ticku, Ceo. Source: SEC Form D and 1 amendment, newest notice filed Mar 11, 2020. Read the notice at the SEC.

equitySEC
Aug 2018$4 MNo. 1$2 to $10 million

C16 Biosciences, Inc.: Raise no. 1, Aug 2018

Investors in this round

33 investors had bought by the notice of Nov 21, 2018: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Shara Ticku · Executive Officer, Director, Promoter
  • Andrew Shumaker · Director, Promoter · He resigned as a Director effective November 20, 2018.
  • David Heller · Director, Promoter
  • Harold McNamara · Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Shara Ticku, President. Source: SEC Form D, newest notice filed Nov 21, 2018. Read the notice at the SEC.

optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • C16 Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2023).

    SEC Form D · Mar 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2023

That is all the official record says: C16 Biosciences, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of C16 Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 45 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by C16 Biosciences, Inc.
NameRoleNamed in
Shara TickuExecutive officerMar 2023
Harold McNamaraDirectorMar 2023
Peter TurnerDirectorMar 2023
Shara TickuDirectorMar 2023
Andrew ShumakerHe resigned as a Director effective November 20, 2018.Nov 2018
David HellerDirectorNov 2018
Shara TickuPromoterMar 2023
David HellerPromoterMar 2020
Harold McNamaraPromoterMar 2020
Andrew ShumakerHe resigned as a Director effective November 20, 2018.Nov 2018